中文
Home>Tianjin Wuqing>Media Center>News

Wuqing’s traditional pharmaceutical enterprise soars after digital transformation

Updated : 2023-11-29

In recent years, traditional pharmaceutical companies have been faced with the challenge of grasping industry trends and exploring high-quality and sustainable development. As a local enterprise that has been deeply rooted in Wuqing district for 27 years, Tianjin Chase Sun Pharmaceutical Co., Ltd. has relied on its own advantages and actively promoted the digital transformation of its industrial chain as a development breakthrough.

4.png

Tianjin Chase Sun Pharmaceutical Co., Ltd. [Photo/WeChat account: China Tianjin Wuqing Development Area]

Established in 1996, Tianjin Chase Sun Pharmaceutical has become a high-tech pharmaceutical and health industry cluster spanning multiple fields, including finished drugs, traditional Chinese medicine, pharmaceutical additives and raw materials, and medical devices.

To further advance the high-quality development of the company, since 2021, Tianjin Chase Sun Pharmaceutical has put efforts into the deep integration of information technology and research, production, and sales business, constructed its big data operational capabilities and promoted business collaboration.

Under this strategy, the company has accelerated the application of digital systems in various stages of R&D and national key laboratories, achieving end-to-end information flow management from drug R&D to market launch. Through digital empowerment, not only has the efficiency of finished drug development been improved, but the technological transformation of business segments, such as traditional Chinese medicine formula granules, has also become smoother.

Its wholly-owned subsidiary company Tcmages Pharmaceutical has realized the Intelligent and automated production process with advanced digital technologies and equipment, greatly improving its production efficiency.

"In the transformation and challenges of the pharmaceutical industry, our company has emerged successfully with its strong research and development innovation capabilities and deep digital transformation strategies," said Lan Wujun, a responsible person of Tianjin Chase Sun Pharmaceutical, "In the future, with the latest scientific research achievements and the advantages of our multi-industry chains layout, we will further promote the rapid development of the pharmaceutical industry."